Academic Journal
1398P Overall survival (OS) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) who received prior androgen deprivation therapy (ADT) and reached low prostate-specific antigen (PSA) levels treated further with enzalutamide (ENZA): Post hoc analyses of ARCHES
| العنوان: | 1398P Overall survival (OS) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) who received prior androgen deprivation therapy (ADT) and reached low prostate-specific antigen (PSA) levels treated further with enzalutamide (ENZA): Post hoc analyses of ARCHES |
|---|---|
| المؤلفون: | Petrylak, D.P., Azad, A.A., Szmulewitz, R.Z., Iguchi, T., Shore, N.D., Holzbeierlein, J., Alekseev, B., El-Chaar, N.N., Rosbrook, B., Ma, J., Zohren, F., Haas, G.P., Stenzl, A., Armstrong, A.J. |
| المصدر: | Annals of Oncology ; volume 33, page S1183-S1184 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2022.07.1884 |
| الاتاحة: | http://dx.doi.org/10.1016/j.annonc.2022.07.1884 https://api.elsevier.com/content/article/PII:S0923753422037358?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753422037358?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| رقم الانضمام: | edsbas.9A3AAF10 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2022.07.1884 |
|---|